In Vitro Diagnostics
BioReference introduces solid tumor genotype test
By
BioReference Laboratories, a provider of laboratory offering testing and information services, has launched its solid tumor genotype test, OnkoMatch.
Diagnostics > In Vitro Diagnostics > News
BioReference Laboratories, a provider of laboratory offering testing and information services, has launched its solid tumor genotype test, OnkoMatch.
Diagnostics > In Vitro Diagnostics > News
SDL, ZyGEM in nucleic acid extraction kits OEM agreement
By
Saudi Diagnostics (SDL) has entered into an OEM agreement to commercilaize ZyGEM's DNA and RNA extraction kits.
Diagnostics > In Vitro Diagnostics > News Roche partners Technoclone to co-develop coagulation assays By
Roche has entered into a collaboration agreement with Technoclone to co-develop a complete range of coagulation assays.
Diagnostics > In Vitro Diagnostics > News
Saudi Diagnostics (SDL) has entered into an OEM agreement to commercilaize ZyGEM's DNA and RNA extraction kits.
Diagnostics > In Vitro Diagnostics > News Roche partners Technoclone to co-develop coagulation assays By
Roche has entered into a collaboration agreement with Technoclone to co-develop a complete range of coagulation assays.
Diagnostics > In Vitro Diagnostics > News
Latest In Vitro Diagnostics News and Insight
View all In Vitro Diagnostics news or find news targeted to your interests
Roche partners Technoclone to co-develop coagulation assays
Roche has entered into a collaboration agreement with Technoclone to co-develop a complete range of coagulation assays.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
Boston IVF introduces saliva test to treat infertility
Boston IVF has launched its first needle-free saliva test for monitoring and treating infertility.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
Mevion to spend $45m on S250 proton therapy system
Mevion Medical Systems has finalized $45m investment from ProQuest Investments and its existing investors.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
IMD Companies changes name to Optimum Mobile Imaging
IMD Companies, a provider of medical diagnostics, has changed its name to Optimum Mobile Imaging.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
Stratify JCV helps to stratify PML Risk in MS patients : Quest Diagnostics
The US Food and Drug Administration (FDA) has granted a de novo classification petition to Quest Diagnostics' Stratify JCV Antibody ELISA testing service.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
EKF Diagnostics continues partnership with MediPurpose
EKF Diagnostics has entered into an agreement to continue its partnership with, OEM medical device provider, MediPurpose.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
LabCorp introduces new ovarian risk assessment tool
Laboratory Corporation of America Holdings (LabCorp) has introduced a new risk stratification tool - ROMA (risk of ovarian malignancy algorithm).
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
Miraculins files PreVu test license application with Health Canada
Miraculins has registered its PreVu Non-Invasive Skin Cholesterol Point of Care (POC) test class II medical device license application with Health Canada.
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
Ventana, Bayer in cancer diagnostic test development agreement
Ventana Medical Systems, a member of the Roche Group, has partnered to develop a molecular companion diagnostic test to identify patients most likely to benefit from Bayer Pharma AG's antibody-drug conjugate (ADC).
Diagnostics > In Vitro Diagnostics > News
Diagnostics > In Vitro Diagnostics > News
MOgene implements Fluidigm Access Array system
MOgene, a provider of genomics services, is implementing Fluidigm's Access Array sample preparation technology for its targeted resequencing customers.
Diagnostics > In Vitro Diagnostics > News
View all In Vitro Diagnostics news or find news targeted to your interests
Diagnostics > In Vitro Diagnostics > News
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Buy online from $3500
